FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Saraswati Saree Depot IPO and Valiant Laboratories IPO.
Saraswati Saree Depot IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Valiant Laboratories IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Saraswati Saree Depot IPO | Valiant Laboratories IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Unistone Capital Pvt Ltd | Unistone Capital Pvt Ltd |
Registrar | Bigshare Services Pvt Ltd | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | Anchor Investor | |
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Saraswati Saree Depot IPO is up to ₹160.01 Cr whereas the issue size of the Valiant Laboratories IPO is up to ₹152.46 Cr. The final issue price of Saraswati Saree Depot IPO is ₹160.00 per share and of Valiant Laboratories IPO is ₹140.00 per share.
Saraswati Saree Depot IPO | Valiant Laboratories IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹152.00 per share | ₹133.00 per share |
Issue Price (Upper) | ₹160.00 per share | ₹140.00 per share |
Issue Price (Final) | ₹160.00 per share | ₹140.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 90 shares | 105 shares |
Fresh Issue Size | 64,99,800 shares | 1,08,90,000 shares |
Fresh Issue Size (Amount) | up to ₹104.00 Cr | up to ₹152.46 Cr |
OFS Issue Size | 35,01,000 shares | |
OFS Issue Size (Amount) | up to ₹56.02 Cr | |
Issue Size Total | 1,00,00,800 shares | 1,08,90,000 shares |
Issue Size Total (Amount) | up to ₹160.01 Cr | up to ₹152.46 Cr |
Saraswati Saree Depot IPO opens on Aug 12, 2024, while Valiant Laboratories IPO opens on Sep 27, 2023. The closing date of Saraswati Saree Depot IPO and Valiant Laboratories IPO is Aug 14, 2024, and Oct 03, 2023, respectively.
Saraswati Saree Depot IPO | Valiant Laboratories IPO | |
---|---|---|
Anchor Bid Date | Aug 09, 2024 | Sep 26, 2023 |
Issue Open | Aug 12, 2024 | Sep 27, 2023 |
Issue Close | Aug 14, 2024 | Oct 03, 2023 |
Basis Of Allotment (Tentative) | Aug 16, 2024 | Oct 05, 2023 |
Initiation of Refunds (Tentative) | Aug 19, 2024 | Oct 06, 2023 |
Credit of Share (Tentative) | Aug 19, 2024 | Oct 06, 2023 |
Listing date (Tentative) | Aug 20, 2024 | Oct 06, 2023 |
Anchor Lockin End date 1 | Sep 15, 2024 | Nov 04, 2023 |
Anchor Lockin End date 2 | Nov 14, 2024 | Jan 03, 2024 |
Saraswati Saree Depot IPO P/E ratio is 17.94, as compared to Valiant Laboratories IPO P/E ratio of 15.71.
Saraswati Saree Depot IPO | Valiant Laboratories IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial | Saraswati Saree Depot Limited Financial Information (Restated Consolidated)Saraswati Saree Depot Limited's revenue increased by 2% and profit after tax (PAT) rose by 29% between the financial year ending with March 31, 2024 and March 31, 2023.
|
Amount in ₹ Crore |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 100% | 100.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 74.75% | 74.94% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 17.94 | 15.71 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹633.60 Cr. | ₹608.30 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 58.88% | 33.73%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 64.46% | 22.76%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.67 | 0.59 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹8.92 | ₹8.91 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 45.49% | 28.86%% |
In the Saraswati Saree Depot IPO retail investors (RII) are offered 35,00,280 shares while in Valiant Laboratories IPO retail investors are offered 35,00,280 shares. Qualified institutional buyers (QIB) are offered 50,00,400 shares in Saraswati Saree Depot IPO and 21,78,030 shares in Valiant Laboratories IPO.
Saraswati Saree Depot IPO | Valiant Laboratories IPO | |
---|---|---|
Anchor Investor Reserveration | 32,66,970 shares | |
Market Maker Reserveration | ||
QIB | 50,00,400 shares | 21,78,030 shares |
NII | 15,00,120 shares | 16,33,500 shares |
RII | 35,00,280 shares | 38,11,500 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 1,00,00,800 shares | 76,23,030 shares |
Saraswati Saree Depot IPO subscribed 107.39x in total, whereas Valiant Laboratories IPO subscribed 29.76x.
Saraswati Saree Depot IPO | Valiant Laboratories IPO | |
---|---|---|
QIB (times) | 64.12x | 20.83x |
NII (times) | 358.47x | 73.64x |
Big NII (times) | 389.28x | 78.64x |
Small NII (times) | 296.85x | 63.64x |
RII (times) | 61.59x | 16.06x |
Employee (times) | ||
Other (times) | ||
Total (times) | 107.39x | 29.76x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|